1. Signaling Pathways
  2. Epigenetics
    PI3K/Akt/mTOR
  3. AMPK
  4. AMPKα Isoform

AMPKα

AMPKα is the catalytic subunit of the heterotrimeric AMP-activated protein kinase (AMPK) complex and includes AMPKα1 and AMPKα2 isoforms[1]. Phosphorylation at Thr172 is critical for AMPK activation, linking upstream kinases including LKB1, CaMKK, and TAK1 to cellular energy signaling[1]. Mechanistically, AMPK coordinates energy homeostasis through lipid metabolism, glucose metabolism, mitochondrial dynamics, and cell-cycle regulation[2]. In disease models, AMPK signaling regulates hepatic steatosis through the AMPK-S6K1-LXRα axis, suppressing lipogenic gene induction and triglyceride accumulation[3]. In cardiovascular research, activated AMPKα isoforms, particularly AMPKα2, remodel energy metabolism, improve mitochondrial dysfunction, activate mitophagy, reduce oxidative stress, and protect cardiac function in heart failure[1]. Compared with related isoforms, AMPKα2 is the predominant catalytic isoform in the heart, whereas AMPKα1 selectively mediates effects of Compound-13/C2 and contributes strongly to lipid-synthesis inhibition in hepatocytes[1][4]. For experimental applications, AMPK activators include indirect and direct agents, but current activators remain limited by incomplete subtype selectivity[1][5].

AMPKα Related Products (1):

Cat. No. Product Name Effect Purity
  • HY-163649
    A17
    Activator 99.4%
    A17 is a bile acid analog with anti-non-alcoholic steatohepatitis (NASH) and anti-inflammatory activities. A17 reduces fatty acid (FA) uptake and promotes FA oxidation though inhibiting fatty acid translocase (Cd36) expression and activating AMPKα. A17 can be used for NASH research.